Amgen Inc. buy phonebroker
Start price
26.03.16
/
50%
€135.16
Target price
17.06.16
€171.27
Performance (%)
0.71%
End price
17.06.16
€135.22
Summary
This prediction ended on 17.06.16 with a price of €135.22. The BUY prediction by phonebroker for Amgen Inc. closed nearly unchanged. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 0.519% | 0.519% | 11.548% | 12.688% |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% | 47.267% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% | 68.687% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 26.03.2016 dem Buy-Gesamtsentiment mit dem Kursziel 189.88$ zu. Der BioTech-Sektor ist in letzter Zeit nicht so gut gelaufen. Das könnte sich in nächster Zeit wieder ändern.
(Stop Loss Kurs erreicht)